🫁 PROMISE Score (Malignant Pleural Effusion)
UseWhen to use: MPE when counseling prognosis and procedure intensity.
StrataGroups A–D map to <25% / 25–50% / 50–75% / ≥75% 3-month mortality.
LimitsWhen not to use: benign effusion pathways. · Pitfall: wrong CRP units. · Not a sole withhold-pleurodesis rule.
SourcePROMISE score (Psallidas et al.)
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Clinical PROMISE.
When to use
When to use: MPE when counseling prognosis and procedure intensity.
How it works
Chemo + RT + Hb + WBC + CRP + ECOG + tumor type points.
Key points
- Clinical PROMISE.
- Four groups.
- Next: goals-of-care talk.
References
- PROMISE score (Psallidas et al.)
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Prior chemotherapy | No (0) |
|---|---|
| Prior radiotherapy | No (0) |
| Hemoglobin (g/dL) | 12–<14 (+2) |
| WBC (×10⁹/L) | 6.3–<10 (+4) |
| CRP (mg/L) | 10–<32 (+5) |
| ECOG performance status | 0–1 (0) |
| Cancer type | Other (+4) |
→PROMISE15pts
- Risk group：A (0–20) — <25% 3-mo mortality
| Prior chemotherapy | No (0) |
|---|---|
| Prior radiotherapy | No (0) |
| Hemoglobin (g/dL) | >16 (0) |
| WBC (×10⁹/L) | <4 (0) |
| CRP (mg/L) | <3 (0) |
| ECOG performance status | 0–1 (0) |
| Cancer type | Mesothelioma (0) |
→PROMISE0pts
- Risk group：A (0–20) — <25% 3-mo mortality
Verification & sources · governance
FAQ
Frequently asked questions
- Does PROMISE Score (Malignant Pleural Effusion) upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is PROMISE Score (Malignant Pleural Effusion) calculated in practice? Can you show a worked example?
- Inputs: Prior chemotherapy No (0), Prior radiotherapy No (0), Hemoglobin (g/dL) 12–<14 (+2), WBC (×10⁹/L) 6.3–<10 (+4), CRP (mg/L) 10–<32 (+5), ECOG performance status 0–1 (0), Cancer type Other (+4) → Result: PROMISE 15 pts（Risk group: A (0–20) — <25% 3-mo mortality） Inputs: Prior chemotherapy No (0), Prior radiotherapy No (0), Hemoglobin (g/dL) >16 (0), WBC (×10⁹/L) <4 (0), CRP (mg/L) <3 (0), ECOG performance status 0–1 (0), Cancer type Mesothelioma (0) → Result: PROMISE 0 pts（Risk group: A (0–20) — <25% 3-mo mortality）